Key statistics
As of last trade Cassava Sciences Inc (PX91:FRA) traded at 26.91, -29.18% below its 52-week high of 38.00, set on Aug 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.08 |
---|---|
High | 34.50 |
Low | 26.91 |
Bid | 25.74 |
Offer | 25.98 |
Previous close | 27.01 |
Average volume | 769.11 |
---|---|
Shares outstanding | 47.98m |
Free float | 41.56m |
P/E (TTM) | -- |
Market cap | 1.54bn USD |
EPS (TTM) | -0.3772 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 15:02 GMT.
More ▼
Announcements
- Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
- Cassava Sciences Reports Q3 2024 Financial and Operating Results
- Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
- Cassava Sciences Resolves SEC Investigation
- Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
- Cassava Sciences Names Rick Barry as Chief Executive Officer
- Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
- Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
- Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
- Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
More ▼